Lilly Officially Pleads Guilty In Zyprexa Debacle

Law360, New York (January 30, 2009, 12:00 AM EST) -- Weeks after Eli Lilly & Co. announced a record-breaking $1.4 billion deal to settle charges that it illegally marketed its anti-psychotic treatment Zyprexa for off-label use, the pharmaceutical giant formally pled guilty Friday to a misdemeanor related to the scandal.

The U.S. Attorney's Office for the Eastern District of Pennsylvania said Lilly — which had already agreed to the plea — officially pled guilty at a hearing in federal court in Philadelphia to “the introduction into interstate commerce of quantities of its drug, Zyprexa, that were...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.